Kareem Zaki - Small Ideas Attract Competition - [Invest Like the Best, EP.392]

Episode Summary

Executive Summary: Patrick O’Shaughnessy interviews Thrive Capital GP Kareem Zaki on how Thrive finds and backs category-defining companies across stages, with special depth in healthcare and AI. Zaki explains Thrive’s concentrated, generalist, lifecycle model, why big problems matter, and how patient capital plus operational support can help startups reshape huge industries.

Main Topics: Thrive’s consistent strategy over time (Priority: 5/5): Despite fund growth, Thrive has kept the same mission: back category-defining companies across stages. Why concentration matters (Priority: 5/5): Thrive prefers a small number of high-conviction bets to deepen support and improve decision quality. Generalist, lifecycle, builder framework (Priority: 5/5): Thrive stays sector-flexible, invests from earliest stages through growth, and helps build companies. What makes a category-definer (Priority: 5/5): Big vision, execution detail, unusual founder traits, and a changing market must all align. Healthcare investing thesis (Priority: 5/5): Healthcare needs big, system-aware, long-term products that work within fragmented, rigid structures. AI and new company formation (Priority: 4/5): AI will transform work, but the biggest short-term wins may come from new categories and operations-heavy rollouts. Team culture and founder empathy (Priority: 4/5): Thrive values mavericks, high horsepower, direct debate, and long-term commitment to founders.

Key Arguments: Thrive’s strategy has stayed consistent since a $40M fund: back category-definers across stages. Generalists avoid sector traps because tech waves are uneven; capital should stay flexible. Concentration improves conviction and lets Thrive be a truly meaningful partner, not one of 1,000. Lifecycle investing helps Thrive understand a company’s arc before and after the first check. Category-definers combine big vision, concrete steps, and a market with real change underway. Big, hard markets can be better than easy SaaS; problems and friction can create moats. Healthcare change requires big products, system integration, and patience, not small MVPs. AI will alter work broadly, but near-term value may come from operational rewiring plus tech. Thrive’s edge comes from being early, being close, and helping founders execute through scale.

Data Points: First institutional fund: $40 million - Josh described Thrive’s earliest institutional fund size Fund size at Kareem’s join: $150 million - Kareem joined Thrive about a decade ago around this fund size Most recent fund: $5 billion - Thrive’s latest fund discussed in the interview Founder count in internal analysis: 120,000 companies - Companies founded in the studied period Category-defining count: 100 to maybe 200 - Thrive’s estimate of real category-defining companies in that universe Companies worth $500 million: 3,000 or so - From the internal cohort analysis Companies worth more than $1 billion: 2,000 - From the internal cohort analysis Capital concentrated in top names: vast majority in 15 names - Typical Thrive fund concentration profile Stripe round after COVID: $7 billion round - Thrive supported Stripe in a major follow-on round Thrive investment in Stripe: nearly $2 billion - Combined support from Thrive and its LPs in that round Healthcare share of federal budget: over 25% - Used to illustrate healthcare’s scale and dysfunction Health care system size: $4.5 trillion - U.S. healthcare described as its own economy Headway employer data point: MTA - Most represented employer in Headway’s early New York data Cedar users served: over 20 million Americans - Cedar’s consumer health billing product scale PBM market concentration: three PBMs capture 80% of the total market - Illustrates healthcare market concentration and lack of competition Thrive operating team size: nine-person investment team - Used to describe decision-making and debate structure Early-stage meeting mix: 80 percent of meetings - Quarterly calendar audit showing Thrive spends most meeting time early-stage Robotic surgery move: early 2000s - Kareem’s father helped pioneer robotic surgery in the Midwest Schools attended: eight different schools - Kareem’s childhood moved frequently due to visa reasons

Pivotal Quotes: "The core DNA of what our strategy was, even from the outside world, you would have looked at us and said, oh, that's a seed Series A fund in New York City, and they're building something around that." — Kareem Zaki: Describing Thrive’s long-term strategic consistency "Busted but booming." — Kareem Zaki: Thrive’s shorthand for companies with strong pull despite imperfect execution "We don't view investing as like an option call or a lottery ticket as sometimes early stage investing could be." — Kareem Zaki: Why Thrive prefers committed, concentrated ownership

Implications: The open question is which new AI and healthcare models can survive long cycles and system friction; founders should build for scale, not novelty, and prove durable pull early.